LPCN - Lipocine - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LPCN is currently covered by 1 analysts with an average price target of $17.02. This is a potential upside of $14.12 (486.9%) from yesterday's end of day stock price of $2.9.

Lipocine's activity chart (see below) currently has 3 price targets and 9 ratings on display. The stock rating distribution of LPCN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 241.5 days.

Highest price target for LPCN is $8, Lowest price target is $8, average price target is $8.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 19-Aug-2025. First documented stock forecast 19-Dec-2016.

Best performing analysts who are covering LPCN - Lipocine:

Dewey Steadman Jennifer Kim Oren Livnat Yi Chen

Currently out of the existing stock ratings of LPCN, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$8

$4.98 (164.90%)

$8

2 months 5 days ago
(19-Aug-2025)

0/4 (0%)

$4.96 (163.16%)

Buy

$51

2 years 2 months 27 days ago
(27-Jul-2023)

0/1 (0%)

$26.69 (109.79%)

Buy

$51

4 years 4 months 28 days ago
(26-May-2021)

1/1 (100%)

$22.61 (79.64%)

228

Hold

$34

$30.98 (1025.83%)

$15

7 years 9 months 14 days ago
(10-Jan-2018)

2/2 (100%)

$2.21 (6.95%)

738

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LPCN (Lipocine) average time for price targets to be met?

On average it took 241.5 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on LPCN (Lipocine) with a proven track record?

DEWEY STEADMAN

Which analyst has the current lower performing score on LPCN (Lipocine) with a proven track record?

YI CHEN

Which analyst has the most public recommendations on LPCN (Lipocine)?

Dewey Steadman has 4 price targets and 5 ratings on LPCN

Which analyst is the currently most bullish on LPCN (Lipocine)?

Dewey Steadman with highest potential upside - $30.98

Which analyst is the currently most reserved on LPCN (Lipocine)?

Jennifer Kim with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?